Insomnia

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
3 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
N Neurology/Psychiatry (ATC N) 3
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase III: 1 Phase IV: 2 Other: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

1 trial
  • Assistance Publique Hopitaux De Paris Academic
    MELATONIN
    2024-516371-32-00 1 country 2026 n=184
    Recruiting

Phase IV

2 trials
  • Idorsia Pharmaceuticals Ltd. Academic
    DARIDOREXANT
    2022-501246-30-00 2 countries 2023 n=35
    Ended
  • Idorsia Pharmaceuticals Ltd. Academic
    DARIDOREXANT
    2022-501246-30-00 2 countries 2023 n=35
    Ended

Other

1 trial
  • Orion Corporation Commercial
    IMP not specified
    2025-524376-36-00 1 country n=24
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Idorsia Pharmaceuticals Ltd. Academic 2 Phase IV 0
Orion Corporation Commercial 1 Other 0
Assistance Publique Hopitaux De Paris Academic 1 Phase III 1
New trials by year
2023
2
2026
1
← All indication landscapes